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Mounting evidence shows that the developing gut micro-biome, particularly immediately after birth, plays an important role in human health1–3. Immune system mat-
uration is orchestrated by early microbial exposures4,5, and early 
childhood immune-mediated disorders including type 1 diabe-
tes (T1D)6, asthma7, juvenile rheumatoid arthritis8, allergic dis-
ease9 and inflammatory bowel disease10 are linked to aberrations 
in gut microbiota. Several human T1D cohort studies reported 
gut microbiota alterations11 and increased intestinal permeabil-
ity12 before diagnosis, but mechanisms connecting gut health to 
autoimmune destruction of pancreatic beta cells remain relatively 
unknown. Complex relationships between the microbiome and 
the immune system13,14 during the first years of life appear critical 
to later life health outcomes but have not been explored at the 
population scale.
Increasingly, microbiome-linked health outcomes appear to 
be consequences of individual strains of specific microbes15–17. 
These outcomes can result from structural variants in the gene 
products of individual strains18, the presence or absence of gene 
cassettes19,20 or currently unexplained mechanisms. Until recently, 
most culture-independent methods for investigating microbiomes 
in large-scale human populations (for example, 16S rRNA gene 
amplicon sequencing) were limited in their resolution of distinct 
microbial strains. Now, efficient metagenomic sequencing and 
culture-independent strain-level analysis methods enable more 
detailed investigation of the early life microbiome.
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The human gut microbiome matures towards the adult composition during the first years of life and is implicated in early 
immune development. Here, we investigate the effects of microbial genomic diversity on gut microbiome development using 
integrated early childhood data sets collected in the DIABIMMUNE study in Finland, Estonia and Russian Karelia. We show 
that gut microbial diversity is associated with household location and linear growth of children. Single nucleotide polymor-
phism- and metagenomic assembly-based strain tracking revealed large and highly dynamic microbial pangenomes, especially 
in the genus Bacteroides, in which we identified evidence of variability deriving from Bacteroides-targeting bacteriophages. Our 
analyses revealed functional consequences of strain diversity; only 10% of Finnish infants harboured Bifidobacterium longum 
subsp. infantis, a subspecies specialized in human milk metabolism, whereas Russian infants commonly maintained a probiotic 
Bifidobacterium bifidum strain in infancy. Groups of bacteria contributing to diverse, characterized metabolic pathways con-
verged to highly subject-specific configurations over the first two years of life. This longitudinal study extends the current view 
of early gut microbial community assembly based on strain-level genomic variation.
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Single-nucleotide polymorphisms (SNPs) accruing in microbial 
genomes over time can be used as a molecular clock to evaluate the 
evolutionary distance between strains of the same species21–24. Such 
approaches have been instrumental in investigating maternal seed-
ing of infant gut microbiomes23,25–28. Complementing SNP-based 
methodologies, metagenomic assembly enables the detection and 
profiling of known and previously unknown metagenomic species 
and genes, as well as gene content-based strain tracking16,29–31. Gene-
centric strain profiling also evaluates functional implications of 
strain-level variability more directly19,20. While SNP- and assembly-
based approaches successfully improved the resolution and clinical 
relevance of many population-level microbiome studies, compari-
sons of these complementary approaches on a single large microbi-
ome data set to identify subpopulations and functional adaptations 
have not been published.
For instance, bifidobacteria are widely characterized beneficial 
commensals, commonly dominating the gut during breastfeeding 
and dissipating throughout life, that possess immunomodulatory 
functions, produce beneficial metabolites and metabolize a range of 
diet-derived, non-digestible carbohydrates32. Subspecies found spe-
cifically in the infant gut typically harbour a wide variety of genes 
enabling the sole use of human milk oligosaccharides (HMOs) for 
energy33. Bifidobacterium longum subsp. infantis (B. infantis)34 and 
some B. longum subsp. longum strains35 are capable of membrane 
transport and intracellular degradation of intact HMOs, whereas 
other B. longum subspecies rely partially on extracellular enzymes 
for HMO utilization36. Culture-independent detection of B. infantis, 
or any other Bifidobacterium strains, in metagenomic data is not 
well established and requires the above-mentioned strain charac-
terization methods.
Here, we characterize strain-specific genomic variation and its 
contribution to the early gut microbiome using an integrated and 
extended data set from DIABIMMUNE, which includes nearly 300 
children with human leukocyte antigen (HLA) haplotypes con-
ferring increased risk to autoimmune disorders (roughly fourfold 
over the background population) in three neighbouring countries: 
Finland, Estonia and Russian Karelia. These children were observed 
for three years from birth by monthly stool sampling, frequent 
questionnaires about common life events and circumstances, and 
periodic blood sampling to track different immune parameters. 
The integrated DIABIMMUNE data set consists of 16S rRNA 
gene sequencing of 3,204 samples and metagenomic sequencing of 
1,154 samples, together spanning 289 subjects at an average of 11.4 
(range 1–36) time points per subject. We briefly report association 
analyses of 16S data followed by SNP- and metagenomic assembly-
based strain and pangenome analyses of common early gut species. 
The integrated DIABIMMUNE microbiome data provide detailed, 
strain-level characterizations of the developing gut microbiome.
Results
DIABIMMUNE followed Finnish, Estonian and Russian children 
for three years from birth by collecting monthly stool samples, 
periodic serum samples and frequent questionnaires on early life 
events. Here, we integrate all published DIABIMMUNE micro-
biome data generated in multiple studies using 16S rRNA ampli-
con, metagenomic and virome sequencing techniques37–40. After 
a unified quality control process, the data consisted of 3,204 16S 
amplicon and 1,154 metagenomic sequencing profiles from 289 
and 269 subjects, respectively (Table 1, Supplementary Fig. 1 and 
Supplementary Table 1).
Early gut microbiome explorations are complicated by natural 
dynamics and numerous interactions with intrinsic and extrinsic 
factors. To further understand early microbial development rela-
tive to these factors, we analysed 16S data using both omnibus and 
individual association tests. Early growth, household location and 
antibiotic courses during pregnancy, among other variables, were 
associated with early gut microbial composition (Supplementary 
Note 1, Supplementary Fig. 1 and Supplementary Tables 2–4). 
Height at age three (Supplementary Fig. 1) and growth rate dur-
ing the first three years of life were positively associated with 
microbial diversity.
Strain diversity and ecology in the early gut. To expand the analy-
sis beyond the genus level typical for 16S data, we leveraged shotgun 
metagenomic data to perform in-depth, strain-level analyses using 
SNPs and gene content. Strain analysis can delineate microbial 
subpopulations22,41 and identify potential functional adaptations in 
the gut microbiome31. Particularly, de novo strain identification is 
important for species with a limited number of isolates, and the gut 
microbiome has many such understudied species despite large cul-
tivation efforts42.
We first characterized dominant strains for the most abundant 
species in the metagenomic data by calling SNPs on conserved 
and unique species-specific marker genes selected from their core 
genomes (that is, genes shared across all strains within the spe-
cies)21. This resulted in a marker gene-based SNP haplotype of the 
dominant strain per species, hereby referred to as the SNP haplo-
type. We then compared SNP haplotypes by sequence similarity 
and stratified them in intra- and inter-subject comparisons (Fig. 1a, 
Supplementary Fig. 2 and Supplementary Table 5). Longitudinal, 
intra-subject comparisons showed more similar strains compared 
to inter-subject comparisons, as previously observed22,43. We found a 
wide range of strain diversities among investigated bacterial species 
(Fig. 1a and Supplementary Table 5): Haemophilus parainfluenzae  
and Faecalibacterium prausnitzii were among the most diverse spe-
cies, with strains having less than 95% sequence similarity in SNP 
haplotype comparisons. Conversely, all investigated members of 
genus Bacteroides had very low sequence variability, with virtu-
ally identical SNP haplotypes in intra-subject comparisons (mean 
sequence similarity 99.96% over an average of 44.3 kb of core 
genome per species) and over 99.6% sequence similarity on aver-
age in inter-subject comparisons. All other species analysed had an 
average inter-subject similarity of 98.9%.
The observed high level of sequence identity in Bacteroides spp. 
contradicted existing evidence of diversity in their gene content44. 
We speculated that the SNP haplotypes did not capture all means of 
microbial genetic diversification, which include lateral gene transfer 
Table 1 | DIABIMMUNE microbiome cohort statistics
Finland Estonia Russia
Study subjects 140 80 73
Samples profiled by 16S 
rRNA gene sequencing 
(median per subject)
2,080 (9) 501 (6) 623 (7)
Samples profiled by 
metagenomic sequencing 
(median per subject)
616 (4) 221 (3) 317 (3)
Males/females 78/62 39/41 40/33
Caesarean sections 9 6 12
Mean maternal age at  
birth (s.d.)
31.1 (4.9) 29.1 (5.1) 27.8 (4.7)
Born in rural household 10 (7.7%) 19 (23.8%) 0
T1D AAB seropositive 
subjects
11 4 1
Subjects with T1D diagnosis 5 1 1
Distribution of study subjects, stool samples with sequencing data and several other external 
variables across the study sites. The table shows the number of study subjects (N) per category 
unless otherwise specified. T1D autoantibody and diagnosis information is as of November 2016.
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Fig. 1 | Strain diversity across species in early gut metagenomes. a, SNP haplotype similarities per species based on all pairwise comparisons (dominant 
strain per species per sample) and stratified to intra-subject and inter-subject comparisons. Species containing > 10 comparisons in both strata are shown. 
b, Gene content similarities (the percentage of shared genes in the smallest of the two genomes) per species, evaluated on pangenomes generated by 
metagenomic assembly. Boxplot colours are as in a. Boxes show the interquartile range (IQR), the vertical line shows the median and the whiskers show 
the range of the data (up to 1.5× IQR). The sample size (n) per boxplot shown in a gives the number of comparisons in a and b. c, Size of the core and 
accessory genomes per species stratified by the functional annotation of genes using eggNOG (known versus unknown function). Entries in a–c are 
ordered according to the size of the metagenomic pangenome. d, Pearson’s correlation coefficients between SNP- and gene content-based similarity 
measures between strains. Sample size (n) is indicated. e, The SNP and gene content similarities of B. dorei strains show low Pearson’s correlation (r =  0.2, 
n =  8,646 comparisons from metagenomes, n =  136 comparisons of isolate genomes). Comparisons between isolate genomes are shown in orange for 
reference. f, SNP and gene content similarities of E. coli strains (Pearson’s r =  0.88, n =  16,110 comparisons).
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(LGT) and niche adaptation. Previously, we identified Bacteroides 
dorei as a highly abundant species potentially interfering with early 
immune maturation39. Therefore, we investigated genome diversity 
further in this species by isolating and sequencing eight B. dorei 
strains from human stool (Supplementary Note 2, Supplementary 
Fig. 2 and Supplementary Tables 6 and 7). Each isolate genome 
harboured between 276 and 1,168 (median 750) unique accessory 
genes representing, on average, 13% of their genomes. Given the 
numbers of unique accessory genes across these B. dorei isolates, 
we wondered whether this diversity was partially owed to LGT by 
bacteriophages.
Bacteriophages contribute to genome plasticity in Bacteroides 
spp. Bacteroides-targeting bacteriophages (phages) are among the 
most common members of the highly diverse human gut virome, 
leading us to evaluate their contribution to the observed genome 
plasticity in this genus. To investigate bacteria–phage interactions 
in the gut, we utilized viral contigs (viromes) assembled using data 
from virus-like particle preparations of 22 DIABIMMUNE sub-
jects40. Using bacterial metagenomes of subjects with viral contig 
data and a designated computational method45 (Supplementary 
Note 3), we reconstructed metagenomic CRISPR arrays that harbour 
spacer sequences targeting phages to which bacteria have adapted a 
response. We found the number of CRISPR spacers in the metage-
nomes reflected the increasing diversity and overall maturation of 
the microbiomes (Supplementary Fig. 3). In total, we identified 
2,463 CRISPR spacers matching sequences in the gut virome across 
all samples, of which 223 matched sequences in the gut virome of 
the same subject (Supplementary Fig. 4 and Supplementary Table 8). 
We found 658 of these spacers in CRISPR cassettes on assembled 
metagenomes, covering 32 bacterial taxa, with B. vulgatus harbour-
ing the most (84, or 28.5% of the spacers matching contigs anno-
tated on a species level), B. dorei harbouring 9 and all Bacteroides 
spp. collectively harbouring 138 spacer sequences (Supplementary 
Table 9). Additionally, when mapped against the virome, 105 (4.2%) 
spacers matched viral contigs annotated as Bacteroides spp. phages. 
These data suggest Bacteroides spp. were exposed to an extensive 
phage repertoire in the children’s guts, providing a plausible mecha-
nism for increased genomic plasticity in Bacteroides.
Metagenomic assembly highlights strain diversification patterns 
within gut species. To explore accessory genome variation more 
broadly and across all taxa, we turned to de novo metagenome 
assembly of DIABIMMUNE metagenomes. This expanded the gene 
pool (number of observed non-redundant genes) to 6,328,944 gene 
families, compared to 1,932,010 gene families found using NCBI 
isolate genomes. Using a co-abundance technique30, we binned the 
assembled metagenomes into metagenomic species and constructed 
pangenomes for 22 species (Fig. 1b,c).
Among all the analysed species, Bacteroides spp. and Escherichia 
coli harboured the largest assembled pangenomes, each with over 
25,000 genes (Fig. 1c), consistent with the high genome plasticity 
reported in these taxa44,46. Consistent with the SNP haplotype analy-
sis, strains recovered from the same individual were more similar to 
each other than to strains found in different individuals (Fig. 1b and 
Supplementary Table 5). The magnitude of variability, however, was 
much higher for gene content than for SNP haplotypes (Fig. 1a,b). 
These measures were highly correlated in most species but showed 
low or no correlation in a minor subset, including F. prausnitzii and 
B. dorei (Fig. 1d). In B. dorei, the results from metagenomic assem-
blies and isolate genomes showed a similar trend, suggesting that 
the incongruity between SNP haplotypes and assembled genomes 
was not an artefact of metagenomic assembly (Fig. 1e). Rather, it 
indicates a more rapid or higher volume diversification in the 
accessory genome compared to the point mutation rate in the core 
genome. In contrast, E. coli metagenome assemblies displayed a high 
correlation between gene content and SNP haplotype similarities 
(Fig. 1f), as previously reported47.
We again used the longitudinal nature of our study to compare 
the difference in gene content between strains from the same or dif-
ferent individuals. On average, B. dorei metagenomic assemblies 
had 88% gene content similarity in intra-subject comparisons and 
significantly lower (69%) similarity in inter-subject comparisons. 
Notably, these values are within the observed range comparing 
B. dorei isolate genomes (Supplementary Fig. 2). H. parainfluenzae, 
an autochthonous oral cavity member, was an outlier with very sim-
ilar intra- and inter-subject gene similarities (65 and 62%, respec-
tively), conceivably reflecting transient gut colonization events and 
frequent replacement with new strains transmitted from the oral 
cavity. A closer investigation of colonization patterns for several 
common oral species in the guts of these children revealed that 
many such species bloomed in Finnish and Estonian infants during 
the first year of life (Supplementary Note 4, Supplementary Fig. 5 
and Supplementary Table 10).
Strain-level variation in Bifidobacterium spp. reflects breastfeed-
ing patterns and geography. Our strain diversity analysis identi-
fied relatively high intra-subject variability in B. longum compared 
to other common Bifidobacterium species, B. bifidum or B. breve  
(Fig. 1a,b). Given the implications of bifidobacteria in immune 
development and early microbial community assembly2,48, we 
sought to explore in more detail the functional consequences of 
this strain-level variation during infancy. To first identify a known 
B. longum subspecies clade, B. infantis, we surveyed the metage-
nomic data for genes of a well-characterized B. infantis cluster 
responsible for HMO transport and degradation34. The presence of 
these genes corresponded with the SNP haplotype-based phylog-
eny of B. longum strains (Fig. 2a,b) and two B. infantis reference 
sequences (ATCC 15697) clustered with 70 strains harbouring these 
genes (highlighted red in Fig. 2a). We found evidence of this gene 
cluster in 14 additional samples, which possibly harboured multi-
ple B. longum strains, of which B. infantis was non-dominant, and 
resulted in a SNP haplotype profile not based on B. infantis.
B. infantis was found in 23.7% (42/177) of stool samples collected 
during breastfeeding but only 3.2% (11/343) of samples collected 
after weaning (excluding samples with low relative abundance of 
B. longum precluding strain identification and samples from sub-
jects with no breastfeeding information), reflecting a clear strain 
shift relative to breastfeeding cessation. Overall, 10% of Finns, 
20% of Estonians and 23% of Russians harboured B. infantis in at 
least one stool sample (either during breastfeeding or after cessa-
tion), suggesting that most subjects in this cohort never obtained 
B. infantis in their gut ecosystems. Comparing B. infantis with other 
B. longum strains revealed evidence of a competitive advantage, 
conferred by the HMO gene cluster or other genomic differences, 
that allows B. infantis to reach higher relative abundances on aver-
age (Fig. 2b), albeit with modest effect sizes.
Probiotics supplements and foods containing commercial strains 
of Bifidobacterium spp. are also a common source of bifidobacteria 
in early life. One such species, B. bifidum, showed contrasting rela-
tive abundances between the countries: unlike Finnish and Estonian 
samples, Russian samples commonly contained over 10% of B. bifi-
dum (Fig. 2c). B. bifidum SNP haplotypes revealed that 79 samples 
from 34 Russians, 3 Estonians and 2 Finns harboured the same 
B. bifidum strain with greater than 99.9% sequence similarity 
(Fig. 2d). This SNP haplotype was identical to the NCBI isolate 
genome B. bifidum 791, which was isolated from a healthy human gut 
in Nizhny Novgorod, Russia and has been patented for medical use in 
Russia. B. bifidum relative abundance was over 10% in 57 of 79 (72%) 
samples containing this strain. While these observations are not direct 
evidence for engraftment of this strain, they show that a probiotic 
strain can obtain high (> 50%) relative abundance in the infant gut.
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Contributional diversity of microbial functions. Finally, we 
approached the developing microbiome from a function-centric 
view49. We binned species based on shared functional pathways and 
assessed their contributional diversity (that is, how diverse sets of 
species encode and have a potential to perform a given function 
per sample)49 for 365 gene ontology (GO) biological process terms 
present in over 100 metagenomes. Most GO terms displayed 
increasing within-sample functional diversity (Gini-Simpson 
index) with increasing age that coincides with microbiome matura-
tion and increasing taxonomic diversity (Fig. 3a and Supplementary 
Table 11). Many widely distributed pathways such as sporulation 
(GO:0030435), glycolysis (GO:0006096) and riboflavin biosynthesis 
a
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Fig. 2 | Bifidobacterium strains in DIABIMMUNE children. a, Phylogenetic tree of B. longum strains in DIABIMMUNE stool samples and 18 NCBI B. longum 
isolate genomes based on SNP haplotypes. Highlighted B. infantis strains (red) include two reference sequences (ATCC 15697). The heatmap illustrates 
strain-specific carriage of 21 genes in the B. infantis HMO gene cluster responsible for intracellular HMO degradation, evaluated using the metagenomic 
data. b, B. longum relative abundance stratified by country and B. longum strain; B. infantis (highlighted red in a) has, on average, higher relative abundance 
compared to other B. longum strains (mixed effects logistic regression P =  0.00049). Boxes shows IQR, vertical lines shows the median and whiskers show 
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(GO:0009231) followed this pattern. Contrastingly, a few specific 
pathways displayed the opposite trend: the aerobic electron trans-
port chain (r = − 0.16, q = 0.001, GO:0019646), viral release from 
host cells (r = − 0.05, q = 1.0, GO:0019076) and the siderophore bio-
synthetic process (r = − 0.07, q = 1.0, GO:0015891) showed decreas-
ing or stable functional diversity within samples over time (Fig. 3a 
and Supplementary Table 11).
Between-sample contributional diversities (beta-diversity, Bray–
Curtis dissimilarity) reflect the stability of functional contributions 
per pathway and can be assessed longitudinally within and across 
subjects. We observed a decreasing longitudinal trend in contri-
butional beta-diversities with increasing age (Fig. 3b, correlation 
between age and beta-diversity, Pearson r = − 0.28, P < 2.2 × 10−16), 
reflecting a change towards a more stable, adult microbial composi-
tion. Microbial contributions to pathways were more stable within 
individuals (Student’s t-test P < 1 × 10−20 in all time windows), as 
reflected by lower beta-diversities, and the gap between intra- and 
inter-subject comparisons tended to widen with time, similar to 
the average beta-diversities of taxonomic profiles (Fig. 3b). This 
provides another perspective of early stabilization of gut microbial 
communities: as pathways in some cases reflect ecological niches 
(for example, aerobic electron transport), the above trend may mir-
ror convergence to specific ecological attractor states, which in turn 
results in stabilization after community adaptation and competition 
over the niche has resolved (Fig. 3b).
Pathways related to bacterial acquisition of iron by siderophores 
(Fig. 3a) provide an example interpreting contributional diversities49. 
Bacteria secrete iron-binding siderophores to harvest iron, 
but extracellular siderophores are exploited by other bacteria. 
According to the black queen hypothesis, the ability to produce such 
costly but necessary molecules is under negative selection until the 
production is minimal but sufficient to support the microbial com-
munity50. Indeed, according to our data, a single dominant species 
per community contributes to siderophore biosynthesis (that is, 
low contributional alpha-diversity, Fig. 3a,c), whereas siderophore 
transport-related genes are more widely distributed across commu-
nity members (Fig. 3a,d).
Discussion
Here, we report a longitudinal, strain-level investigation of the 
developing gut microbiome utilizing the DIABIMMUNE cohort 
and its rich metadata of various life events. We integrated all 
published microbiome data, resulting in 3,204 16S amplicon and 
1,154 metagenomic sequencing profiles from 289 and 269 sub-
jects, respectively. This integrated data set will serve as a reference 
resource for the microbiome research community. Furthermore, 
our analyses contribute to taxonomic and functional understand-
ings of early gut communities.
A strain can be defined experimentally (a single clonal iso-
late) or operationally (a combination of variants detected in a 
metagenomic assembly, phased haplotype or collection of reads) 
as used here. SNP and gene content profiling offer complemen-
tary means of tracking microbial strains in metagenomic data. 
While metagenomes can provide information on many strains 
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simultaneously, the depth of resolution on any one strain is lim-
ited. SNP-based methods usually operate within a few percentage 
points of each genome that serves as a marker region for evaluating 
evolutionary distance within a population21–24. Evaluating the gene 
content of microbial strains offers more direct means for functional 
interpretation of any observed differences19,20. For most species, 
these approaches provided highly concordant phylogenetic popula-
tion structures, as evidenced by the high correlation between SNP 
haplotype and gene content similarities. In some species, such as 
F. prausnitzii and B. dorei, however, these measures did not cor-
relate. F. prausnitzii is a phylogenetically diverse clade consisting of 
distinct subspecies clades that blur the distinction between strain 
tracking and species differentiation and potentially confound the 
methodologies for tracking strains41. We isolated and sequenced 
eight high-quality B. dorei genomes that confirmed this obser-
vation. For these and similar species, such as B. adolescentis and 
R. intestinalis, the observed lack of correlation may stem from the 
difference between the timescales at which the measures operate; 
rapid genetic adaptation driven by promiscuous LGT and gene loss 
contrasted by slower, long-term SNP acquisition may confound 
the correlation51. The consequence of most of these adaptations for 
strain fitness or symbiosis with the host early in life, especially con-
sidering the known immunomodulatory effects of specific strains, 
remains to be elucidated.
This study contributes several observations on another group of 
bacteria common in early childhood, Bifidobacterium. We observed 
virtually identical B. bifidum strains in 79, mostly Russian, samples. 
This analysis demonstrates that microbial strains may be shared on 
the population level and such strain-level trends can be detected 
from metagenomic data. The observed strain, B. bifidum 791, has 
been patented for medical use in Russia (http://russianpatents.
com/patent/216/2165454.html), and local regulation allows add-
ing such bacterial components to infant formulas (GOST 30626–98 
‘Dry milk products for infant feeding’ http://gostexpert.ru/data/
files/30626-98/0f82d40248598989307bf0a50b573429.pdf). Our 
communication with locals confirmed that this strain is common 
in baby formula and other infant food products. Therefore, these 34 
Russian infants potentially obtained this strain, which may achieve 
stable engraftment, as a probiotic supplement. This observation sup-
ports the idea that early gut microbial assembly can be intervened 
by probiotics48, which can confer beneficial effects such as restora-
tion of healthy growth52 and protection against immune-mediated 
diseases53 or the adverse effects of antibiotic courses54.
There are consequential differences in HMO processing capa-
bilities within Bifidobacterium species that underscore the impor-
tance of identifying bacterial strains in this genus. We detected 
B. infantis in metagenomic data by both its HMO processing genes 
and SNP haplotype profile. We observed B. infantis in only 10% of 
Finns in this cohort, suggesting that this keystone species may be 
less prevalent in Finnish gut ecosystems. Among other effects, this 
may lead to elevated faecal pH levels, further promoting inflamma-
tion-favouring bacteria and gut dysbiosis55. A probiotic trial adding 
B. infantis to breast milk during the first weeks of life demonstrated 
persistent B. infantis engraftment and beneficial alterations in intes-
tinal fermentation48. Our data corroborate the notion that intracel-
lular HMO utilization provides B. infantis a competitive advantage 
over other HMO-consuming species, allowing B. infantis to domi-
nate the infant gut during breastfeeding. Based on these findings 
and the literature (reviewed by Insel and Knip56), we hypothesize 
that natively resident or supplemented B. infantis during breast-
feeding drives a shift in gut microbial community structure, shap-
ing subsequent ecology and potentially immune development and/
or protection against immune disorders in genetically predisposed 
populations. This could be tested by further characterization of the 
associated bifidobacterial functional diversity and by randomized, 
placebo-controlled clinical trials in humans.
Methods
DIABIMMUNE cohort. The DIABIMMUNE cohort recruitment took place 
between September 2008 and July 2011 in Finland, Estonia and Russia. Families 
with a newborn infant with HLA DR-DQ alleles conferring increased risk for 
autoimmunity, determined by a cord blood test, were invited to join the study. 
The parents gave their written informed consent prior to sample collection. The 
study participants were monitored for infections, use of antibiotics, breastfeeding, 
introduction of complementary foods and other life events on study visits at 
months 3, 6, 12, 18, 24 and 36 from birth. During these visits, maternal information 
and events during the pregnancy were collected using a questionnaire. Serum 
samples were collected from all subjects during visits to the clinic at the following 
time points: 0 (cord blood), 3, 6, 12, 18, 24 and 36 months. Diabetes-associated 
autoantibodies were analysed as previously described37. The DIABIMMUNE study 
was conducted according to the guidelines in the Declaration of Helsinki, and all 
procedures involving human subjects were approved by the Ethical Committee 
for Psychiatric Diseases and Diseases in Children and Adolescents, Helsinki and 
Uusimaa Hospital District (Finland), the Ethics Review Committee on Human 
Research of the University of Tartu (Estonia) and the Ethical Committee, Ministry 
of Health and Social Development, Karelian Republic of the Russian Federation 
(Russia). More information about the cohort and data collection can be found in 
other DIABIMMUNE publications37–39 and online at http://www.diabimmune.org/ 
and https://pubs.broadinstitute.org/diabimmune/.
For the statistical association testing described below, additional information 
(external variables) about the subjects was pre-processed as follows. The external 
variables were categorized into two categories: generic and complex variables. 
Here, generic variables (maternal age at delivery, gestational diabetes, gestational 
age in days, mode of delivery, gender, country of birth, cohort and HLA risk 
class) information was available for all subjects and contained no missing values. 
Complex variables, on the other hand, contained missing values and in many cases 
required pre-processing and exact defining beforehand (for example, antibiotics 
courses, maternal illnesses during pregnancy, urban or rural family location 
when the child was born, daycare attendance and elder siblings). As breastfeeding 
information was not available for all the subjects and reduced the sample sizes 
significantly in cross-sectional analyses, it was not considered a generic variable. 
While the associations between the generic variables and the gut microbial 
communities were modelled together in one analysis, the associations of complex 
variables were determined by modelling them one by one with all generic variables.
16S sequencing analysis. 16S rRNA gene sequencing was conducted essentially 
as previously described57. Paired-end sequencing reads were demultiplexed using 
ea-utils command line tools (https://codfor exampleoogle.com/p/ea-utils/) and 
clustered into operational taxonomic units (OTUs) using the UPARSE pipeline58. 
Reads were quality-filtered using the UPARSE quality-filtering threshold of 
Emax = 1, at which the most probable number of base errors per read is zero for 
filtered reads59. Filtered reads were trimmed to a fixed length, singletons removed 
and then clustered de novo into OTUs, with simultaneous chimaera filtering. 
Taxonomic classification of OTUs was performed against the Greengenes version 
13.8 16S rDNA database60. The full OTU table was filtered by removing samples 
with fewer than 3,000 OTU counts and by removing OTUs appearing in less than 
5% of samples (178 samples). This resulted in an OTU table consisting of 3,204 
samples from 289 subjects and 920 OTUs.
Permutational multivariate analysis of variance (PERMANOVA) between the 
external variables and gut microbiomes was performed on 16S rRNA amplicon 
sequencing data of samples collected roughly at 2 (between 0 and 90 days), 6 (170 
and 260 days) and 18 months (510 to 600 days) of age using the adonis function 
in the vegan R package (default parameters). Per each subject, the sample closest 
to the exact cross-section time under analysis was chosen, resulting in 140, 184 
and 202 samples per time window, respectively. The order of external variables 
in the multivariable PERMANOVA model formula was determined by first 
analysing each variable individually using a univariable PERMANOVA model 
and then ordering the variables based on the significance of their association (that 
is, permuted P value) from the most to the least significant in the multivariable 
PERMANOVA model. The statistical significance of PERMANOVA results was 
evaluated by permutation test with 10,000 permutations.
Individual associations between bacterial genera and external variables were 
tested using MaAsLin, which conducts outlier removal, feature selection and 
linear modeling61. Association analyses were performed in both cross-sectional 
and longitudinal manners. The cross-sectional analyses were conducted on the 
same samples from the time windows chosen for the PERMANOVA analyses, 
where all variables of the analyses (only generic variables or generic and one added 
complex variable) were used as fixed effects. In the longitudinal analyses, subject 
IDs were used as a random effect, and all the generic variables and breastfeeding 
information were used as fixed effects. In the case a complex variable was added 
to the analysis, it was also used as a fixed effect. With these effect settings in 
longitudinal analyses, a total of 2,586 samples from 237 subjects were available, 
where the numbers varied according to the complex variable added to the analysis 
and the amount of missing values it introduced. For both the cross-sectional 
and longitudinal analyses, genus-level 16S rRNA microbiome data were used for 
identifying taxonomic-level associations of the external variables.
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Metagenomic sequencing. Metagenomic shotgun sequencing was conducted 
as previously described37–39. Additional sequencing data were generated for 45 
samples that were excluded from a previous investigation39 due to low read count 
and are indicated in Supplementary Table 1. Quality control for the metagenomic 
shotgun sequencing data was conducted using kneadData v0.4.6.1 with additional 
automatic adapter detection and trimming at a minimum overlap of 5 bp by Trim 
Galore!. Taxonomic profiles were generated using MetaPhlAn v2.662 and functional 
profiling was done by HUMAnN2 v0.10.049, which provides gene family level (here, 
90% similarity) quantifications of microbial genes that are further stratified by 
contributing organisms. The gene families were further mapped to GO63 terms as 
previously described39. Strain SNP haplotypes were generated using StrainPhlAn21 
by requiring a minimum coverage of 10 bases for SNP calling (‘–min_read_depth 
10’ command line parameter for sample2markers.py).
Metagenomic assembly. Metagenomic reads were assembled into contigs using 
MegaHIT64, individually for each sample, followed by an open reading frame 
prediction using Prodigal65. A non-redundant gene catalogue was constructed in 
a fashion similar to earlier approaches29 by clustering genes based on sequence 
similarity at 95% identity and 90% coverage of the shorter sequence using 
CD-HIT66. Subsequently, the gene catalogue was merged with the IGC gene 
catalogue67 using the same criteria to create a more comprehensive reference 
gene catalogue for the gut microbiome. Only genes detected in DIABIMMUNE 
samples (~6 million) were used in the downstream analysis. Gene abundance 
was estimated by mapping quality trimmed reads from each sample to the gene 
catalogue with Burrows–Wheeler Aligner (BWA)68. This served as an input for 
binning genes into metagenomic species using canopy clustering, which finds 
core genes for each metagenomic species30. Metagenomic species with at least 400 
genes were retained for further analysis. To extend the analysis beyond core genes 
we detected accessory genes in each sample in which the metagenomic species 
was present, in the following manner. We recruited genes co-assembled on the 
same contigs as core genes as long as the abundances of these genes were between 
the 10th and 90th percentiles of the abundances of core genes in a sample. Core 
genes and accessory genes grouped together in this manner across all samples 
defined the metagenomic pangenome of a species. To define a metagenomic 
strain, we used the same 10th and 90th percentiles of the abundances of core genes 
criteria to determine the specific accessory genes from the pangenome associated 
with the core genes of a metagenomic species in a sample. Similarity between 
pairs of metagenomic strains within species was measured using the percentage 
of shared genes in the smallest of the two genomes, as established previously47. 
Assembled genes were annotated with clusters of orthologous groups (COG), 
Kyoto encyclopedia of genes and genomes (KEGG) and GO terms using eggnog 
mapper69, and at species, genus and phylum levels with NCBI RefSeq (version July 
2017), as described previously67.
Phylogenetic trees. Phylogenetic trees (Fig. 2a,d and Supplementary Fig. 5) were 
generated based on StrainPhlAn SNP haplotypes using the phangorn R package70. 
Briefly, similarities between strain haplotypes were computed using the Jukes and 
Cantor (JC69) model, and an initial tree was constructed using Unweighted Pair 
Group Method with Arithmetic Mean (UPGMA) hierarchical clustering. The tree 
was optimized using the maximum likelihood method, by iterative optimization 
of edge lengths, base frequencies and topology. Visualizations were generated 
using the ggtree R package. For B. bifidum (Fig. 2d), strains with > 99.5% sequence 
similarity were collapsed to a single tip and represented by the strain with the 
lowest average distance to other strains before optimizing the phylogenetic tree.
B. dorei isolate genomes. B. dorei colonies were isolated from serial dilutions of 
DIABIMMUNE and PRISM (Prospective Registry in IBD Study at Massachusetts 
General Hospital) stool samples plated on selective and non-selective media after 
being incubated anaerobically at 37 °C for 72 h. To isolate high-molecular-weight 
DNA for PacBio sequencing (Pacific Biosciences), the isolates were grown on 
brain heart infusion agar supplemented (sBHI) with 10% fetal bovine serum 
(Hyclone), 1% haemin/vitamin K solution (BD), 1% trace vitamins (ATCC), 1% 
trace minerals (ATCC), 0.5 g l−1 cysteine hydrochloride (Sigma), 1 g l−1 maltose, 
1 g l−1 fructose (VWR) and 1 g l−1 cellubiose (Sigma) anaerobically at 37 °C for 72 h. 
Colonies were transferred to 30 ml sBHI broth and grown anaerobically for 48 h. 
Cells were centrifuged at 4,450 r.p.m. for 10 min and supernatant was discarded. 
DNA was extracted using the Genomic-tip 500/G kit (Qiagen) according to 
the manufacturer’s instructions. After isopropanol treatment, precipitated 
DNA was spooled and transferred to 70% ethanol in a 1.2 ml tube and left to 
dry in a clean PCR hood for 4 h. Dried DNA was resuspended in elution buffer 
(Qiagen). DNA fragment size was measured with a 4200 TapeStation (Agilent) 
using a Genomic DNA ScreenTape (Agilent). PacBio sequencing libraries were 
constructed by the blunt-ended ligation of SMRTbell adapter sequences to needle-
sheared genomic DNA according to the manufacturer’s instructions (Pacific 
Biosciences). The libraries were damage-repaired using the SMRTbell Damage 
Repair Kit (Pacific Biosciences) following the manufacturer’s instructions and 
subsequently size-selected on a Blue Pippin with an 8 kb cutoff and then loaded on 
a Sequel sequencing instrument with MagBeads according to the manufacturer’s 
instructions (Pacific Biosciences). The genomes were assembled using the internal 
PacBio assembler HGAP4. Reads less than 6 kb in length were excluded from the 
assembly process.
The assembled B. dorei genomes were analysed using PanPhlAn71 (default 
settings) together with five existing isolate genomes in NCBI. The resulting non-
redundant gene catalogue was annotated by translated DIAMOND search72 against 
the UniRef90 and UniRef50 databases and by enforcing UniRef ’s clustering criteria. 
We primarily used UniRef90 annotations, if available, but applied UniRef50 
annotation in the absence of UniRef90 annotation.
B. longum gene analysis. B. longum HMO gene presence in the metagenomic 
samples (Fig. 2a) was determined as follows. We identified UniRef90 gene 
families corresponding to the protein sequences in the B. infantis HMO gene 
cluster34 (protein sequences Blon_2331–Blon_2361 in the NCBI protein sequence 
database) using a translated BLAST search against the B. longum pangenome in 
the ChocoPhlAn pangenome collection73 utilized by HUMAnN2. Specifically, we 
required ≥ 90% alignment identify and ≥ 80% mutual coverage (corresponding 
to the definition of UniRef90 gene families) and accepted only the best hit per 
protein sequence. Combining this information with HUMAnN2 species-stratified 
UniRef90 gene family quantification enabled calling these genes present as long  
as they had sufficient read coverage, here defined as log10(counts-per-million/ 
B. longum relative abundance) > 1.
Contributional diversities of metagenomic functions. The contributional 
diversities of the metagenomic functions were analysed as described previously49. 
Briefly, stratified abundances of metagenomic functions were first renormalized 
after excluding any ‘unclassified’ relative abundance. Contributional diversity  
for a given metagenomic function was then calculated by applying ecological 
similarity measures to the stratified abundance of that function. The Gini–Simpson 
index was used for alpha-diversity, and Bray–Curtis dissimilarity was used  
for beta-diversity.
CRISPR array detection and mapping. CRISPR spacers and repeat sequences 
were searched using Crass version 0.3.845. We mapped all identified 42,412 
CRISPR spacers sequences to viral contigs of 112 samples with viromic data using 
bowtie2 version 2.3.4.174 with the parameters ‘-N 1 –local –no-unal’ and exported 
the results in bam format using ‘samtools view -bS -’ with an overall alignment 
rate of 5.81% (2,463 aligned spacers). Alignment of the 42,412 spacers and 3,272 
repeats against the full set of metagenomic assembled contigs (n = 5,368,547) was 
performed with the same bowtie2 setting, resulting in overall alignment rates of 
73 and 95% for spacers and repeats, respectively. We determined the number of 
spacers and repeats matching the contigs of the DIABIMMUNE assembly and 
marked 658 spacers matching a virome contig in which repeat matches were also 
found. The majority of the repeats (93%) had multiple matches in the assembly, as 
expected for CRISPR repeats.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Code availability. The analysis software used for quality control and taxonomic 
and functional profiling is publicly available in bioBakery at https://bitbucket.org/
biobakery/biobakery/ and referenced as appropriate. More detailed analysis scripts 
are available upon request.
Data availability
All 16S rRNA and metagenomic sequencing data are available in the NCBI 
Sequence Read Archive under BioProject PRJNA497734 and through the 
DIABIMMUNE microbiome website at https://pubs.broadinstitute.org/
diabimmune/.
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